Attention A T users. To access the menus on this page please perform the following steps.
1. Please switch auto forms mode to off.
2. Hit enter to expand a main menu option (Health, Benefits, etc).
3. To enter and activate the submenu links, hit the down arrow.
You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.
Specific author contributions: Each author participated in a consensus development process, which occurred between January and December 2011. Each author participated in regular conference calls during this time, reviewed relevant medical literature, wrote and revised sections of the manuscript, and approved the final draft of the manuscript.
Financial support: None.
Potential competing interests: None.
Contributors: Veterans Health Administration, Office of Public Health/Clinical Public Health, Washington, DC: Janet Durfee, RN, MSN, APRN (acting chief consultant); Technical Advisory Group: Matt B. Goetz, MD, Samuel B. Ho, MD; Core Working Group for the VA HCV Treatment Recommendations: Helen S. Yee, PharmD, Michael F. Chang, MD, Christine Pocha, MD, Joseph Lim, MD, David Ross, MD, PhD, Timothy R. Morgan, MD, Alexander Monto, MD.